Memorial Sloankettering Cancer Center is a company based in New York, New York that has hired a total of 18 Perm Visa Employees as of across 2 locations, with the majority of hires in NY.
The primary jobs hired include Biological Technicians, Statisticians, and Biological Scientists, All Other.
The average salary at Memorial Sloankettering Cancer Center for the jobs listed above is $58,213.95.
This company has mostly hired people from the Specialty (except Psychiatric and Substance Abuse) Hospitals industry
The company has been hiring employees since at least 2020, and both the number of Perm employees and the average salary has been rising over time.
Memorial Sloankettering Cancer Center has a Perm Visa approval rate of 45.00% .
Memorial Sloankettering Cancer Center
633 Third Avenue, 5th Floor
New York,
NEW YORK
40
$70,050.85
18 Approved
0 Denied
1 Withdrawn
21 Certified Expired
| Job Title | Job Location | Salary | Number Of Jobs |
|---|---|---|---|
| Biological Technicians | New York, Ny | $42,068.17 | 6 |
| Statisticians | New York, Ny | $73,861.00 | 2 |
| Biological Scientists, All Other | New York, Ny | $82,659.00 | 2 |
| Database Administrators | New York, Ny | $84,552.00 | 2 |
| Computer Occupations, All Other | New York, Ny | $89,398.00 | 2 |
| Compensation And Benefits Managers | New York, Ny | $123,074.00 | 1 |
| Network And Computer Systems Administrators | Middletown, Nj | $101,566.00 | 1 |
| Healthcare Social Workers | New York, Ny | $77,688.00 | 1 |
| Industrial Engineers | New York, Ny | $88,525.00 | 1 |
Memorial Sloankettering Cancer Center has been in the Perm Visa program since 2020 where they hired 7 employees. They peaked in 2021 with 8 employees, and have since been on a decline with the most recent number of employees being 2 in 2023.
Memorial Sloankettering Cancer Center has been in the Perm Visa program since 2020 where the average salary was $70,974. They peaked in 2021 with an average salary of $72,950, and have since been on a decline with the most recent average salary being $68,776 in 2023.